Document and Entity Information
Document and Entity Information - shares | 3 Months Ended | |
Mar. 31, 2021 | May 21, 2021 | |
Entity Listings [Line Items] | ||
Entity Registrant Name | Figure Acquisition Corp. I | |
Entity Central Index Key | 0001839550 | |
Current Fiscal Year End Date | --12-31 | |
Document Type | 10-Q | |
Amendment Flag | false | |
Document Period End Date | Mar. 31, 2021 | |
Document Fiscal Year Focus | 2021 | |
Document Fiscal Period Focus | Q1 | |
Entity Address, State or Province | CA | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | true | |
Entity Ex Transition Period | false | |
Entity Shell Company | true | |
Class A Common Stock [Member] | ||
Entity Listings [Line Items] | ||
Entity Common Stock, Shares Outstanding | 28,750,000 | |
Class B Common Stock [Member] | ||
Entity Listings [Line Items] | ||
Entity Common Stock, Shares Outstanding | 3,194,444 | |
Class L Common Stock [Member] | ||
Entity Listings [Line Items] | ||
Entity Common Stock, Shares Outstanding | 9,126,984 |
CONDENSED BALANCE SHEET
CONDENSED BALANCE SHEET - USD ($) | Mar. 31, 2021 | Dec. 31, 2020 |
Current assets: | ||
Cash | $ 985,917 | $ 25,000 |
Prepaid Expenses | 586,663 | 0 |
Total current assets | 1,572,580 | 25,000 |
Deferred offering costs | 0 | 49,366 |
Cash and securities held in Trust Account | 287,500,000 | 0 |
Total Assets | 289,072,580 | 74,366 |
Current liabilities: | ||
Accrued offering costs and expenses | 67,509 | 57,500 |
Promissory note - related party | 0 | 0 |
Total current liabilities | 67,509 | 57,500 |
Deferred underwriting fee | 10,062,500 | 0 |
Warrant liability | 16,183,959 | 0 |
Total liabilities | 26,313,968 | 57,500 |
Commitments and Contingencies | ||
Class A Common Stock subject to possible redemption, 25,775,861 and 0 shares at redemption value, at March 31, 2021 and December 31, 2020, respectively | 257,758,610 | 0 |
Stockholders' Equity: | ||
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding | 0 | 0 |
Additional paid-in capital | 3,107,208 | 23,768 |
Retained earnings (accumulated deficit) | 1,861,821 | (8,134) |
Total stockholders' equity | 5,000,002 | 16,866 |
Total Liabilities and stockholders' equity | 289,072,580 | 74,366 |
Class A Common Stock [Member] | ||
Stockholders' Equity: | ||
Common stock | 29,741 | 0 |
Class B Common Stock [Member] | ||
Stockholders' Equity: | ||
Common stock | 319 | 319 |
Class L Common Stock [Member] | ||
Stockholders' Equity: | ||
Common stock | $ 913 | $ 913 |
CONDENSED BALANCE SHEET (Parent
CONDENSED BALANCE SHEET (Parenthetical) - $ / shares | Mar. 31, 2021 | Feb. 23, 2021 | Dec. 31, 2020 |
Stockholders' Equity: | |||
Preferred stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 | |
Preferred stock, shares authorized (in shares) | 1,000,000 | 1,000,000 | |
Preferred stock, shares issued (in shares) | 0 | 0 | |
Preferred stock, shares outstanding (in shares) | 0 | 0 | |
Common stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 | |
Common stock, shares authorized (in shares) | 15,000,000 | 15,000,000 | |
Common stock, shares issued (in shares) | 9,126,984 | 9,126,984 | |
Common stock, shares outstanding (in shares) | 9,126,984 | 9,126,984 | |
Class A Common Stock [Member] | |||
Liabilities and Stockholders' Equity: | |||
Class A common stock, shares subject to possible redemption (in shares) | 25,775,861 | 0 | |
Stockholders' Equity: | |||
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.0001 | $ 0.01 |
Common stock, shares authorized (in shares) | 100,000,000 | 100,000,000 | |
Common stock, shares issued (in shares) | 2,974,139 | 0 | |
Common stock, shares outstanding (in shares) | 2,974,139 | 0 | |
Class B Common Stock [Member] | |||
Stockholders' Equity: | |||
Common stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 | |
Common stock, shares authorized (in shares) | 10,000,000 | 10,000,000 | |
Common stock, shares issued (in shares) | 3,194,444 | 3,194,444 | |
Common stock, shares outstanding (in shares) | 3,194,444 | 3,194,444 | |
Class L Common Stock [Member] | |||
Stockholders' Equity: | |||
Common stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 | |
Common stock, shares authorized (in shares) | 15,000,000 | 15,000,000 | |
Common stock, shares issued (in shares) | 9,126,984 | 9,126,984 | |
Common stock, shares outstanding (in shares) | 9,126,984 | 9,126,984 |
CONDENSED STATEMENT OF OPERATIO
CONDENSED STATEMENT OF OPERATIONS | 3 Months Ended |
Mar. 31, 2021USD ($)$ / sharesshares | |
Loss from Operations | |
Formation and operating costs | $ 71,283 |
Loss from operations | (71,283) |
Other Income [Abstract] | |
Interest earned on cash and marketable securities held in Trust Account | 0 |
Offering costs allocated to warrants | (621,678) |
Change in fair value of warrant liability | 2,562,916 |
Total other income | 1,941,238 |
Net income | 1,869,955 |
Class A Common Stock Subject to Possible Redemption [Member] | |
Other Income [Abstract] | |
Interest earned on cash and marketable securities held in Trust Account | $ 0 |
Basic weighted average shares outstanding (in shares) | shares | 25,517,968 |
Diluted weighted average shares outstanding (in shares) | shares | 25,517,968 |
Basic net income per share (in dollars per share) | $ / shares | $ 0 |
Diluted net income per share (in dollars per share) | $ / shares | $ 0 |
Non-redeemable Common Stock [Member] | |
Other Income [Abstract] | |
Net income | $ 1,869,955 |
Basic weighted average shares outstanding (in shares) | shares | 12,703,724 |
Diluted weighted average shares outstanding (in shares) | shares | 12,703,724 |
Basic net income per share (in dollars per share) | $ / shares | $ 0.15 |
Diluted net income per share (in dollars per share) | $ / shares | $ 0.15 |
CONDENSED STATEMENT OF CHANGES
CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - 3 months ended Mar. 31, 2021 - USD ($) | Common Stock [Member]Class A Common Stock [Member] | Common Stock [Member]Class B Common Stock [Member] | Common Stock [Member]Class L Common Stock [Member] | Additional Paid-in Capital [Member] | Retained Earnings [Member] | Total | Class B Common Stock [Member] |
Beginning balance at Dec. 31, 2020 | $ 0 | $ 319 | $ 913 | $ 23,768 | $ (8,134) | $ 16,866 | |
Beginning balance (in shares) at Dec. 31, 2020 | 0 | 3,194,444 | 9,126,984 | ||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Sale of Units, net of underwriting discount and offering expenses | $ 287,500 | $ 0 | $ 0 | 271,581,166 | 0 | 271,868,666 | |
Sale of Units, net of underwriting discount and offering expenses (in shares) | 28,750,000 | ||||||
Sale of Private Placement warrants | $ 0 | 0 | 0 | 7,750,000 | 0 | 7,750,000 | |
Initial classification of warrant liability | 0 | 0 | 0 | (18,746,875) | 0 | (18,746,875) | |
Net income | 0 | 0 | 0 | 0 | 1,869,955 | 1,869,955 | $ 1,869,955 |
Class A common stock subject to possible redemption | $ (257,759) | 0 | 0 | (257,500,851) | 0 | (257,758,610) | |
Class A common stock subject to possible redemption (in shares) | (25,775,861) | ||||||
Ending balance at Mar. 31, 2021 | $ 29,741 | $ 319 | $ 913 | $ 3,107,208 | $ 1,861,821 | $ 5,000,002 | |
Ending balance (in shares) at Mar. 31, 2021 | 2,974,139 | 3,194,444 | 9,126,984 |
CONDENSED STATEMENT OF CHANGE_2
CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical) - shares | Feb. 23, 2021 | Mar. 31, 2021 |
Private Placement Warrants [Member] | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||
Warrants issued (in shares) | 5,166,667 | 5,166,667 |
CONDENSED STATEMENT OF CASH FLO
CONDENSED STATEMENT OF CASH FLOWS | 3 Months Ended |
Mar. 31, 2021USD ($) | |
Cash flows from operating activities: | |
Net income | $ 1,869,955 |
Adjustments to reconcile net income to net cash used in operating activities: | |
Interest earned on marketable securities held in Trust Account | 0 |
Offering costs allocated to warrants | 621,678 |
Change in fair value of warrant liability | (2,562,916) |
Changes in operating assets and liabilities: | |
Prepaid assets | (586,663) |
Accrued expenses | 26,925 |
Net cash provided by operating activities | (631,021) |
Cash Flows from Investing Activities: | |
Investment of cash in Trust Account | (287,500,000) |
Net cash used in investing activities | (287,500,000) |
Cash Flows from Financing Activities: | |
Proceeds from sale of Units, net of underwriting discount | 281,750,000 |
Proceeds from issuance of Private Placement Warrants | 7,750,000 |
Proceeds from promissory note - related party | 115,492 |
Repayment of promissory note - related party | (115,492) |
Payment of offering costs | (408,062) |
Net cash provided by financing activities | 289,091,938 |
Net change in cash | 960,917 |
Cash, beginning of period | 25,000 |
Cash, end of the period | 985,917 |
Supplemental disclosure of non-cash financing activities: | |
Initial classification of common stock subject to possible redemption | 257,758,610 |
Initial classification of warrant liability | 18,901,875 |
Deferred underwriters' discount payable charged to additional paid-in capital | $ 10,062,500 |
Organization and Business Opera
Organization and Business Operations | 3 Months Ended |
Mar. 31, 2021 | |
Organization and Business Operations [Abstract] | |
Organization and Business Operations | Note 1 — Organization and Business Operations Figure Acquisition Corp. I (the “Company”) is a newly organized blank check company incorporated as a Delaware corporation on December 15, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (“Business Combination”). As of March 31, 2021, the Company had not commenced any operations. All activity through March 31, 2021 relates to the Company’s formation and the Initial Public Offering (“IPO”) which is described below, and identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering The registration statement for the Company’s IPO was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on February 18, 2021 (the “Effective Date”). On February 23, 2021, the Company consummated the IPO of 28,750,000 units ( (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public Shares the full exercise by the underwriters of the over-allotment option to purchase an additional 3,750,000 Units Simultaneously with the closing of the IPO, the Company consummated the sale of 5,166,667 Private Placement Warrants (the “Private Placement Warrants”), at a price of $1.50 per Private Placement Warrant, in a private placement to Fintech Acquisition LLC, a Delaware limited liability company (the “Sponsor”), Transaction costs of the IPO amounted to $ 16,253,012 consisting of $5,750,000 of underwriting discount, $10,062,500 of deferred underwriting discount, and $440,512 of other offering costs of which $621,678 were allocated to expense associated with the warrant liability. Following the closing of the IPO on February 23, 2021, $287,500,000 ($10.00 per Unit) from the net offering proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) and invested in U.S. government treasury bills with a maturity of 185 days or less or in money market funds investing solely in U.S. Treasuries, as determined by the Company, until the earlier of: (a) the completion of the Company’s initial Business Combination, (b) the redemption of any shares of the Company’s Class A common stock sold in the Proposed Public Offering (the “public shares”) properly submitted in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation (i) to modify the substance or timing of the Company’s obligation to provide for the redemption of the public shares in connection with the initial Business Combination or to redeem 100% of the Company’s public shares if it does not complete its initial Business Combination within 24 months from the closing of the Proposed Public Offering or (ii) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity, and (c) the redemption of 100% of the Company’s public shares if the Company is unable to complete the initial Business Combination within 24 months from the closing of the Public Offering, subject to applicable law The Company will provide its public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination either (i) in connection with a stockholder meeting called to approve the initial Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a proposed initial Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem their shares for a pro rata share of the aggregate amount then on deposit in the Trust Account (initially approximately $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations) . The Company will have 24 months from February 23, 2021, the closing of the Public Offering, to complete an initial Business Combination (the “Combination Period”). However, if the Company is unable to complete its initial Business Combination within the Combination Period, the Company will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law . The Sponsor, officers and directors have agreed to (i) waive their redemption rights with respect to their shares of the Company’s Class B common stock (the “founder shares”), shares of Class L common stock and public shares in connection with the completion of the initial Business Combination, (ii) waive their redemption rights with respect to their founder shares, shares of Class L common stock and public shares in connection with a stockholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation (A) to modify the substance or timing of the Company’s obligation to provide for the redemption of the public shares in connection with an initial Business Combination or to redeem 100% of the public shares if the Company does not complete the initial Business Combination within the Combination Period or (B) with respect to any other material provisions relating to stockholder’s rights or pre-initial Business Combination activity, (iii) waive their rights to liquidating distributions from the Trust Account with respect to their founder shares and shares of Class L common stock if the Company fails to complete the initial Business Combination within the Combination Period, and (iv) vote any founder shares held by them and any public shares purchased during or after the Public Offering (including in open market and privately-negotiated transactions) in favor of the Company’s initial Business Combination . The Company’s Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable), nor will it apply to any claims under the Company’s indemnity of the underwriters of the Public Offering against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked its Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether its Sponsor has sufficient funds to satisfy its indemnity obligations and believes that the Company’s Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure that its Sponsor would be able to satisfy those obligations . Liquidity and Capital Resources As of March 31, 2021, the Company had approximately $1.0 million in its operating bank account, and working capital of approximately $1.5 million. The Company’s liquidity needs up to February 23, 2021 had been satisfied through a capital contribution from the Sponsor of $25,000 (see Note 6) for the founder shares and the loan under an unsecured promissory note from the Sponsor of up to $300,000 which was paid in full on February 23, 2021 from the IPO proceeds (see Note 6). Subsequent to the consummation of the IPO, the Company’s liquidity needs have been satisfied through the net proceeds from the consummation of the Private Placement not held in the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, our Sponsor or an affiliate of our Sponsor, or certain of our officers and directors may, but are not obligated to, provide us working capital loans. As of March 31, 2021, there were no amounts outstanding under any working capital loan. Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, we will be using these funds held outside of the Trust Account for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination. Risks and Uncertainties Management is continuing to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that it could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. |
Restatement of Previously Issue
Restatement of Previously Issued Financial Statements | 3 Months Ended |
Mar. 31, 2021 | |
Restatement of Previously Issued Financial Statements [Abstract] | |
Restatement of Previously Issued Financial Statements | Note 2 — Restatement of Previously Issued Financial Statements In May 2021, the Company concluded that, because of a misapplication of the accounting guidance related to its Public and Private Placement warrants the Company issued in February 2021, the Company’s previously issued balance sheet as of February 23, 2021 on Form 8-K should no longer be relied upon. As such, the Company is restating its balance sheet in this Quarterly Report. On April 12, 2021, the staff of the Securities and Exchange Commission (the “SEC Staff”) issued a public statement entitled “Staff Statement on Accounting and Reporting Considerations for Warrants issued by Special Purpose Acquisition Companies (“SPACs”)” (the “SEC Staff Statement”). In the SEC Staff Statement, the SEC Staff expressed its view that certain terms and conditions common to SPAC warrants may require the warrants to be classified as liabilities on the SPAC’s balance sheet as opposed to equity. Since issuance on February 23, 2021, the Company’s warrants were accounted for as equity within the Company’s previously reported balance sheet, and after discussion and evaluation, including with the Company’s independent auditors, management concluded that the warrants should be presented as liabilities with subsequent fair value remeasurement. Historically, the Warrants were reflected as a component of equity as opposed to liabilities on the balance sheet based on our application of FASB ASC Topic 815-40, Derivatives and Hedging, Contracts in Entity’s Own Equity (“ASC 815-40). The views expressed in the SEC Staff Statement were not consistent with the Company’s historical interpretation of the specific provisions within its warrant agreement and the Company’s application of ASC 815-40 to the warrant agreement. The Company reassessed its accounting for Warrants issued on February 23, 2021, in light of the SEC Staff’s published views. Based on this reassessment, management determined that the Warrants should be classified as liabilities measured at fair value upon issuance, with subsequent changes in fair value reported in the Company Statement of Operations each reporting period. Therefore, the Company, in consultation with its Audit Committee, concluded that its previously issued balance sheet as of February 23, 2021, should be restated because of a misapplication in the guidance around accounting for certain of our outstanding warrants to purchase common stock (the “Warrants”) and should no longer be relied upon. Impact of the Restatement The impact to the balance sheet dated February 23, 2021, filed on Form 8-K on March 1, 2021 related to the impact of accounting for public and private warrants as liabilities at fair value resulted in a $18.9 million increase to the warrant liabilities line item on February 23, 2021 and offsetting decrease to the Class A common stock subject to redemption mezzanine equity line item. Transaction costs of the IPO of $621,678 were allocated to expense associated with the warrant liability, which is reflected in the change to the accumulated deficit line. The liability associated with the Private Warrants in excess of the Private Placement proceeds resulted in a non-operating expense of $155,000, which is reflected in the change to the accumulated deficit line. There is no change to total stockholders' equity at any reported balance sheet date. As of February 23, 2021 As Previously Reported Restatement Adjustment As Restated Total assets $ 290,100,262 $ — $ 290,100,262 Liabilities and stockholders’ equity: Total current liabilities $ 937,354 $ — $ 937,354 Warrant liabilities — 18,901,875 18,901,875 Total liabilities 11,090,346 18,901,875 33,147,810 Class A common stock, $0.0001 par value; stock subject to possible redemption 274,009,910 (18,901,875 ) 255,108,035 Stockholders’ equity Class A common stock - $0.0001 par value 135 189 324 Additional paid-in-capital 5,010,711 776,489 5,787,200 Accumulated deficit (12,072 ) (776,678 ) (788,750 ) Total stockholders’ equity 5,000,006 — 5,000,006 Total liabilities and stockholders’ equity $ 290,100,262 $ — $ 290,100,262 |
Significant Accounting Policies
Significant Accounting Policies | 3 Months Ended |
Mar. 31, 2021 | |
Significant Accounting Policies [Abstract] | |
Significant Accounting Policies | Note 3 — Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented The interim results for the three months ended March 31, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future interim periods. Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of March 31, 2021 and December 31, 2020. Marketable Securities Held in Trust Account At March 31, 2021, substantially all of the assets held in the Trust Account were held in money market funds which invest U.S. Treasury securities. Warrant Liabilities The Company evaluated the Public Warrants and Private Placement Warrants (collectively, “Warrants”, which are discussed in Note 2, Note 4, Note 5 and Note 9) in accordance with ASC 815-40, “Derivatives and Hedging — Contracts in Entity’s Own Equity”, and concluded that a provision in the Warrant Agreement related to certain tender or exchange offers precludes the Warrants from being accounted for as components of equity. As the Warrants meet the definition of a derivative as contemplated in ASC 815, the Warrants are recorded as derivative liabilities on the Condensed Balance Sheet and measured at fair value at inception (on the date of the IPO) and at each reporting date in accordance with ASC 820, “Fair Value Measurement”, with changes in fair value recognized in the Condensed Statement of Operations in the period of change. Offering Costs Associated with the Initial Public Offering The Company complies with the requirements of the ASC 340-10-S99-1. Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering . Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as non-operating expenses in the statement of operations. Offering costs associated with the Class A common stock were charged to stockholders’ equity upon the completion of the Initial Public Offering. Transaction costs amounted to $ 16,253,012, of which $621,678 were allocated to expense associated with the warrant liability. Common Stock Subject to Possible Redemption The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheets. Income Taxes The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized . The deferred tax assets were deemed to be de minimis as of March 31, 2021 and December 31, 2020. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition . The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2021 and December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income tax examinations by major taxing authorities since inception. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The provision for income taxes was deemed to be de minimis for the period ended March 31, 2021. Net Income Per Common Share Net income per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. The Company applies the two-class method in calculating earnings per share. Shares of common stock subject to possible redemption at March 31, 2021, which are not currently redeemable and are not redeemable at fair value, have been excluded from the calculation of basic net loss per common share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. The Company has not considered the effect of warrants sold in the Initial Public Offering and the private placement to purchase 12,354,167 shares of common stock in the calculation of diluted income per share, since the exercise of the warrants are contingent upon the occurrence of future events. As a result, diluted net income per common share is the same as basic net income per common share for the period presented Reconciliation of Net Income per Common Share The Company’s net income is adjusted for the portion of income that is attributable to common stock subject to possible redemption, as these shares only participate in the earnings of the Trust Account and not the income or losses of the Company. Accordingly, basic and diluted loss per common share is calculated as follows: For the Three Months Ended March 31, 2021 Redeemable Class A Common Stock Numerator: Earnings allocable to Redeemable Class A Common Stock Interest earned on cash and marketable securities held in Trust Account $ - Net income allocable to shares subject to possible redemption $ - Denominator: Weighted Average Redeemable Class A Common Stock Basic and diluted weighted average shares outstanding 25,517,968 Basic and diluted net income per share $ - Non-Redeemable Class A and Class B Common Stock Numerator: Net Income minus Net Earnings Net income $ 1,869,955 Less: Income attributable to common stock subject to possible redemption - Adjusted net income $ 1,869,955 Denominator: Weighted Average Non-Redeemable Class A and Class B Common Stock Basic and diluted weighted average shares outstanding 12,703,724 Basic and diluted net income per common share $ 0.15 Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. Recent Accounting Pronouncements Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements. |
Initial Public Offering
Initial Public Offering | 3 Months Ended |
Mar. 31, 2021 | |
Initial Public Offering [Abstract] | |
Initial Public Offering | Note 4 — Initial Public Offering Public Units On February 23, 2021, the Company sold 28,750,000 Units, at a purchase price of $10.00 per Unit, which included the full exercise by the underwriters of the over-allotment option to purchase an additional 3,750,000 Units Public Warrants Each whole warrant entitles the holder to purchase one share of the Company’s Class A common stock at a price of $11.50 per share, subject to adjustment as discussed herein. The warrants will become exercisable on the later of 12 months from February 23, 2021, the closing of the Public Offering, or 30 days after the completion of its initial Business Combination, and will expire five years after the completion of the Company’s initial Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, (i) in the case of any such issuance to the Sponsor or any of its respective affiliates, without taking into account any founder shares or shares of Class L common stock held by the Sponsor or such affiliates, as applicable, prior to such issuance, and (ii) to the extent that such issuance is made to the Sponsor or any of its respective affiliates, without taking into account the transfer of founder shares, shares of Class L common stock or private placement warrants by the Sponsor in connection with such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below in “Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00” and “Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger described below in “Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price . The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the shares of Class A common stock underlying the warrants is then effective and a prospectus relating thereto is current. No warrant will be exercisable and the Company will not be obligated to issue shares of Class A common stock upon exercise of a warrant unless Class A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In no event will the Company be required to net cash settle any warrant. In the event that a registration statement is not effective for the exercised warrants, the purchaser of a unit containing such warrant will have paid the full purchase price for the unit solely for the share of Class A common stock underlying such unit . Redemption of Warrants When the Price per of Class A Common Stock Equals or Exceeds $18.00 Once the warrants become exercisable, the Company may redeem the outstanding warrants : ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon not less than 30 days’ prior written notice of redemption (the “30-day redemption period”) ; and ● if, and only if, the last reported sale price of the Class A common stock for any 20 trading days within a 30-trading day period ending three trading days before we send the notice of redemption to the warrant holders (which we refer to as the “Reference Value”) equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and certain issuances of Class A common stock and equity-linked securities) . The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the issuance of the Class A common stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A common stock is available throughout the 30-day redemption period. If and when the warrants become redeemable, the Company may exercise its redemption right even if unable to register or qualify the underlying securities for sale under all applicable state securities laws. Redemption of Warrants When the Price per of Class A Common Stock Equals or Exceeds $10.00 Once the warrants become exercisable, the Company may redeem the outstanding warrants : ● in whole and not in part; ● at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption, provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the “fair market value” of the Class A common stock (as defined below in the immediately following paragraph) except as otherwise described below ; ● if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted per stock splits, stock dividends, reorganizations, recapitalizations and the like and certain issuances of Class A common stock and equity-linked securities) ; and ● if the Reference Value is less than $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and certain issuances of Class A common stock and equity-linked securities), the private placement warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants, as described above . The “fair market value” of the Class A common stock for the above purpose shall mean the volume-weighted average price of the Class A common stock as reported during the ten trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. The Company will provide our warrant holders with the final fair market value no later than one business day after the ten-trading day period described above ends. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 shares of Class A common stock per whole warrant (subject to adjustment). If a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. In such event, each holder would pay the exercise price by surrendering the warrants for that number of shares of Class A common stock equal to the lesser of (A) the quotient obtained by dividing (x) the product of the number of shares of Class A common stock underlying the warrants, multiplied by the excess of the “fair market value” of the Class A common stock over the exercise price of the warrants by (y) the fair market value and (B) 0.361 per whole warrant. The “fair market value” as used in this paragraph shall mean the average last reported sale price of the Class A common stock for the ten trading days ending on the third trading day prior to the date on which the notice of exercise is received by the warrant agent. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis . |
Private Placement
Private Placement | 3 Months Ended |
Mar. 31, 2021 | |
Private Placement [Abstract] | |
Private Placement | Note 5 — Private Placement Simultaneously with the closing of the IPO, the Sponsor purchased an aggregate of 5,166,667 Private Placement Warrants at a price of $1.50 per Private Placement Warrant, for an aggregate purchase price of $7,750,000, in a private placement . A portion of the proceeds from the private placement was added to the proceeds from the IPO held in the Trust. The Private Placement Warrants are identical to the Public Warrants sold in the IPO except that the Private Placement Warrants, so long as they are held by the initial stockholders or its permitted transferees, (i) they will not be redeemable by the Company for cash, (ii) they (including the Class A common stock issuable upon exercise of these warrants) may not, subject to certain limited exceptions, be transferred, assigned or sold until 30 days after the completion of the Company’s initial Business Combination, and (iii) they may be exercised by the holders on a cashless basis. If the Private Placement Warrants are held by holders other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by the holders on the same basis as the warrants included in the Units being sold in the IPO . |
Related Party Transactions
Related Party Transactions | 3 Months Ended |
Mar. 31, 2021 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | Note 6 — Related Party Transactions Founder Shares In December 2020, the Company’s Sponsor purchased 4,107,143 shares of Class B common stock and 8,214,286 shares of Class L common stock for a capital contribution of $25,000, or approximately $0.002 per share. In January 2021, the Company’s Sponsor surrendered its Class B and Class L shares, and the Company reissued to the Sponsor 3,194,444 shares of Class B common stock (the “founder shares”) and 9,126,984 shares of Class L common stock, with no return of capital or payment by the Sponsor, resulting in the Sponsor holding 3,194,444 shares of Class B common stock (the “founder shares”) and 9,126,984 shares of Class L common stock, including an aggregate of up to 416,667 shares of Class B common stock and up to 1,190,476 shares of Class L common stock subject to forfeiture, respectively, if the over-allotment option was not exercised by the underwriters in full. As a result of the underwriters’ election to fully exercise their over-allotment option on February 23, 2021, none of the Class B shares or Class L shares are subject to forfeiture any longer . With certain limited exceptions, the founder shares are not transferable, assignable or saleable (except to the Company’s officers and directors and other persons or entities affiliated with the Sponsor, including their respective limited partners, each of whom will be subject to the same transfer restrictions) until the earlier of (A) one year after the completion of the Company’s initial Business Combination or (B) subsequent to the Company’s initial Business Combination, (x) if the reported closing price of Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Company’s initial Business Combination or (y) the date, following the completion of the Company’s initial Business Combination, on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property . Promissory Note — Related Party On December 22, 2020, Company issued an unsecured promissory note to the Sponsor for an aggregate of up to $300,000 to cover expenses related to the IPO. This loan was non-interest bearing and payable on the earlier of June 30, 2021 or the completion of the IPO. During the period from January 1, 2021 to February 23, 2021, the Company had borrowed $115,492 under the promissory note. On February 25, 2021, the Company paid the note balance in full from the proceeds of the IPO. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $2,000,000 of such Working Capital Loans may be convertible into warrants at a price of $1.50 per warrant at the option of the lender. The warrants would be identical to the Private Placement Warrants, including as to exercise price, exercisability and exercise period . At March 31, 2021, no Working Capital Loans were outstanding. |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Mar. 31, 2021 | |
Commitments and Contingencies [Abstract] | |
Commitments and Contingencies | Note 7 — Commitments and Contingencies Registration Rights The Sponsor will have rights to require the Company to register any of its securities held by them for resale under the Securities Act pursuant to a registration and stockholder rights agreement to be signed prior to or on the effective date of the Public Offering. These holders will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities for sale under the Securities Act. In addition, the holders of the founder shares, Private Placement Warrants and warrants that may be issued upon conversion of working capital loans (and any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of working capital loans and upon conversion of the founder shares) will have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. Underwriting Agreement The underwriter had a 45-day option from the date of the IPO to purchase up to an aggregate of 3,750,000 additional Units at the public offering price less the underwriting commissions to cover over-allotments, if any. On February 23, 2021, the underwriter fully exercised the over-allotment option, and was paid a fixed underwriting discount of 2% of the gross proceeds of the IPO, or $5,750,000 in aggregate. The underwriters are entitled to deferred underwriting fee of 3.5% of the gross proceeds of the IPO, or $10,062,500 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. |
Stockholders' Equity
Stockholders' Equity | 3 Months Ended |
Mar. 31, 2021 | |
Stockholders' Equity [Abstract] | |
Stockholders' Equity | Note 8 — Stockholders’ Equity Preferred Stock — The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 and with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors Class A Common Stock — The Company is authorized to issue a total of 100,000,000 shares of Class A common stock at par value of $0.01 each Class B Common Stock — The Company is authorized to issue a total of 10,000,000 shares of Class B common stock at par value of $0.0001 per share The Company’s sponsor, directors and officers have agreed not to transfer, assign or sell their founder shares until the earlier to occur of (A) one year after the completion of the Company’s initial Business Combination or (B) subsequent to the Company’s initial Business Combination, (x) if the reported closing price of the Company’s Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Company’s initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange, or other similar transaction that results in all of its stockholders having the right to exchange their shares of common stock for cash, securities or other property. The shares of Class B common stock will automatically convert into shares of the Company’s Class A common stock at the time of its initial Business Combination on a one-for-one basis, subject to adjustment pursuant to certain anti-dilution rights, as described herein. In the case that additional shares of Class A common stock or equity-linked securities are issued or deemed issued in connection with the Company’s initial Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 10% of the sum of (i) the total number of all shares of common stock outstanding upon the completion of the Public Offering, plus (ii) the total number of shares of Class A common stock and equity-linked securities issued or deemed issued in connection with or in connection with the initial Business Combination, excluding any shares of Class A common stock or equity-linked securities issued, or to be issued, to any seller in the initial business combination and any units or warrants issued to our sponsor or its affiliates upon conversion of Working Capital Loans; provided that such conversion of founder shares will never occur on a less than one for one basis. Prior to the initial Business Combination, only holders of the Company’s Class B common stock will have the right to vote on the election of directors. With respect to any other matter submitted to a vote of the Company’s stockholder, holders of record of the Class A common stock and holders of record of the Class B common stock will vote together as a single class, with each share of common stock entitling the holder to one vote except as required by law. Class L Common Stock —The Company is authorized to issue a total of 15,000,000 shares of Class L common stock at par value of $0.0001 each. At March 31, 2021 and December 31, 2020, there were 9,126,984 shares issued and outstanding. The Class L common stock shall have no voting rights and will convert into shares of Class A common stock following the initial Business Combination to the extent certain triggering vesting events occur. The Class L common stock will vest in four equal tranches upon achieving share performance targets. If between the consummation of our initial business combination and the ten year anniversary of the initial Business Combination the closing price of the Company's Class A common stock equals or exceeds specified per share trading price targets for any 20 trading days within a 30-trading day period (the four vesting price targets equal $12.50 ("First Price Vesting"), $15.00 ("Second Price Vesting"), $17.50 ("Third Price Vesting"), and $20.00 ("Fourth Price Vesting")), one-fourth of the Class L common shares will automatically convert into Class A common shares on a 1-for-1 basis. For example, if fifteen months following the consummation of the initial Business Combination the closing price of the shares of Class A common stock equals or exceeds $15.00 but does not exceed $17.50 for 20 trading days within a 30-trading day period, both the First Price Vesting and Second Price Vesting target achievements will be met, resulting in a total of 3,968,254 Class L Shares converting into 3,968,254 shares of Class A common stock, representing 1,984,127 shares associated with the First Price Vesting and 1,984,127 shares associated with the Second Price Vesting (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like). For purposes of the foregoing price vesting targets, if the Company consummates any liquidation, merger, share exchange, reorganization or other similar transaction after its initial business combination and before the tenth anniversary of its initial business combination (a "Strategic Transaction") which results in all of the public stockholders having the right to exchange their common stock for cash, securities or other property, then the Company’s board of directors will determine in good faith the effective price per share of Class A common stock in such Strategic Transaction. This effective price will dictate how many remaining shares of Class L common stock convert on a one-for-one basis to shares of Class A common stock, based on the foregoing price vesting targets. For example, if the Company consummates a Strategic Transaction and the First and Second Price Vesting targets have previously been achieved and the effective price in such Strategic Transaction is determined to be $17.50, then 1,984,127 shares of Class L common stock will convert at the closing of such Strategic Transaction on a one-for-one basis to 1,984,127 shares of Class A common stock, and any remaining shares of Class L common stock will be forfeited. Further, for example, if the Company consummates a Strategic Transaction and the First and Second Price Vesting targets have previously not been achieved and the effective price in such Strategic Transaction is determined to be $17.50, then 5,952,381 shares of Class L common stock will convert at the closing of such Strategic Transaction on a one-for-one basis to 5,952,381 shares of Class A common stock, and any remaining shares of Class L common stock will be forfeited. In contrast, if the Company consummates a Strategic Transaction and the First and Second Price Vesting targets have previously been achieved and the effective price in such Strategic Transaction is determined to be only $14.00, then under the Strategic Transaction threshold, no shares of Class L common stock will convert because no additional price vesting target has been achieved; thus, none of the remaining shares of Class L common stock will convert to shares of Class A common stock at the closing of such Strategic Transaction, and any remaining shares of Class L common stock will be forfeited. |
Fair Value Measurements
Fair Value Measurements | 3 Months Ended |
Mar. 31, 2021 | |
Fair Value Measurements [Abstract] | |
Fair Value Measurements | Note 9 — Fair Value Measurements The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1 — Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment. Level 2 — Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means. Level 3 — Valuations based on inputs that are unobservable and significant to the overall fair value measurement. The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at March 31, 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: March 31, Quoted Prices In Active Markets Significant Other Observable Inputs Significant Other Unobservable Inputs 2021 (Level 1) (Level 2) (Level 3) Assets: U.S. Money Market held in Trust Account $ 287,500,000 $ 287,500,000 $ - $ - Liabilities: Public Warrants Liability $ 9,415,625 - - $ 9,415,625 Private Placement Warrants Liability 6,768,334 - - 6,768,334 $ 16,183,959 $ - $ - $ 16,183,959 The Warrants are accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the Condensed Balance Sheet. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the Condensed Statement of Operations. The Company established the initial fair value of the Public Warrants and Private Warrants on February 23, 2021, the date of the Company’s Initial Public Offering, and as of March 31, 2021, using a Monte Carlo simulation model. The Warrants were classified as Level 3 at the initial measurement date and subsequent measurement date due to the use of unobservable inputs. The key inputs into the Monte Carlo simulation as of February 23, 2021 and March 31, 2021 were as follows: Inputs (Initial Measurement) February 23, 2021 March 31, 2021 Risk-free interest rate 0.80 % 1.10 % Expected term remaining (years) 6.0 5.89 Expected term until Merger (years) 1.0 0.89 Estimated probability of successful Merger 50.0 % 50.0 % Expected volatility Pre-Merger 10.0 % 10.0 % Expected volatility Post-Merger 50.0 % 50.0 % Implied Stock price $ 10.86 $ 9.80 Exercise price $ 11.50 $ 11.50 |
Subsequent Events
Subsequent Events | 3 Months Ended |
Mar. 31, 2021 | |
Subsequent Events [Abstract] | |
Subsequent Events | Note 10 — Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements. |
Significant Accounting Polici_2
Significant Accounting Policies (Policies) | 3 Months Ended |
Mar. 31, 2021 | |
Significant Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented The interim results for the three months ended March 31, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future interim periods. |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of March 31, 2021 and December 31, 2020. |
Marketable Securities Held in Trust Account | Marketable Securities Held in Trust Account At March 31, 2021, substantially all of the assets held in the Trust Account were held in money market funds which invest U.S. Treasury securities. |
Warrant Liabilities | Warrant Liabilities The Company evaluated the Public Warrants and Private Placement Warrants (collectively, “Warrants”, which are discussed in Note 2, Note 4, Note 5 and Note 9) in accordance with ASC 815-40, “Derivatives and Hedging — Contracts in Entity’s Own Equity”, and concluded that a provision in the Warrant Agreement related to certain tender or exchange offers precludes the Warrants from being accounted for as components of equity. As the Warrants meet the definition of a derivative as contemplated in ASC 815, the Warrants are recorded as derivative liabilities on the Condensed Balance Sheet and measured at fair value at inception (on the date of the IPO) and at each reporting date in accordance with ASC 820, “Fair Value Measurement”, with changes in fair value recognized in the Condensed Statement of Operations in the period of change. |
Offering Costs Associated with the Initial Public Offering | Offering Costs Associated with the Initial Public Offering The Company complies with the requirements of the ASC 340-10-S99-1. Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering . Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as non-operating expenses in the statement of operations. Offering costs associated with the Class A common stock were charged to stockholders’ equity upon the completion of the Initial Public Offering. Transaction costs amounted to $ 16,253,012, of which $621,678 were allocated to expense associated with the warrant liability. |
Common Stock Subject to Possible Redemption | Common Stock Subject to Possible Redemption The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheets. |
Income Taxes | Income Taxes The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized . The deferred tax assets were deemed to be de minimis as of March 31, 2021 and December 31, 2020. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition . The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2021 and December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income tax examinations by major taxing authorities since inception. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The provision for income taxes was deemed to be de minimis for the period ended March 31, 2021. |
Net Income Per Common Share | Net Income Per Common Share Net income per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. The Company applies the two-class method in calculating earnings per share. Shares of common stock subject to possible redemption at March 31, 2021, which are not currently redeemable and are not redeemable at fair value, have been excluded from the calculation of basic net loss per common share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. The Company has not considered the effect of warrants sold in the Initial Public Offering and the private placement to purchase 12,354,167 shares of common stock in the calculation of diluted income per share, since the exercise of the warrants are contingent upon the occurrence of future events. As a result, diluted net income per common share is the same as basic net income per common share for the period presented |
Reconciliation of Net Income per Common Share | Reconciliation of Net Income per Common Share The Company’s net income is adjusted for the portion of income that is attributable to common stock subject to possible redemption, as these shares only participate in the earnings of the Trust Account and not the income or losses of the Company. Accordingly, basic and diluted loss per common share is calculated as follows: For the Three Months Ended March 31, 2021 Net income $ 1,869,955 Less: Income attributable to common stock subject to possible redemption - Adjusted net income $ 1,869,955 Weighted average shares outstanding, basic and diluted 11,910,032 Basic and diluted net income per common share $ 0.16 |
Concentration of Credit Risk | Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. |
Recent Accounting Pronouncements | Recent Accounting Pronouncements Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements. |
Restatement of Previously Iss_2
Restatement of Previously Issued Financial Statements (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Restatement of Previously Issued Financial Statements [Abstract] | |
Restatement of Previously Issued Financial Statements | The impact to the balance sheet dated February 23, 2021, filed on Form 8-K on March 1, 2021 related to the impact of accounting for public and private warrants as liabilities at fair value resulted in a $18.9 million increase to the warrant liabilities line item on February 23, 2021 and offsetting decrease to the Class A common stock subject to redemption mezzanine equity line item. Transaction costs of the IPO of $621,678 were allocated to expense associated with the warrant liability, which is reflected in the change to the accumulated deficit line. The liability associated with the Private Warrants in excess of the Private Placement proceeds resulted in a non-operating expense of $155,000, which is reflected in the change to the accumulated deficit line. There is no change to total stockholders' equity at any reported balance sheet date. As of February 23, 2021 As Previously Reported Restatement Adjustment As Restated Total assets $ 290,100,262 $ — $ 290,100,262 Liabilities and stockholders’ equity: Total current liabilities $ 937,354 $ — $ 937,354 Warrant liabilities — 18,901,875 18,901,875 Total liabilities 11,090,346 18,901,875 33,147,810 Class A common stock, $0.0001 par value; stock subject to possible redemption 274,009,910 (18,901,875 ) 255,108,035 Stockholders’ equity Class A common stock - $0.0001 par value 135 189 324 Additional paid-in-capital 5,010,711 776,489 5,787,200 Accumulated deficit (12,072 ) (776,678 ) (788,750 ) Total stockholders’ equity 5,000,006 — 5,000,006 Total liabilities and stockholders’ equity $ 290,100,262 $ — $ 290,100,262 |
Significant Accounting Polici_3
Significant Accounting Policies (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Significant Accounting Policies [Abstract] | |
Reconciliation of Net Income per Common Share | The Company’s net income is adjusted for the portion of income that is attributable to common stock subject to possible redemption, as these shares only participate in the earnings of the Trust Account and not the income or losses of the Company. Accordingly, basic and diluted loss per common share is calculated as follows: For the Three Months Ended March 31, 2021 Redeemable Class A Common Stock Numerator: Earnings allocable to Redeemable Class A Common Stock Interest earned on cash and marketable securities held in Trust Account $ - Net income allocable to shares subject to possible redemption $ - Denominator: Weighted Average Redeemable Class A Common Stock Basic and diluted weighted average shares outstanding 25,517,968 Basic and diluted net income per share $ - Non-Redeemable Class A and Class B Common Stock Numerator: Net Income minus Net Earnings Net income $ 1,869,955 Less: Income attributable to common stock subject to possible redemption - Adjusted net income $ 1,869,955 Denominator: Weighted Average Non-Redeemable Class A and Class B Common Stock Basic and diluted weighted average shares outstanding 12,703,724 Basic and diluted net income per common share $ 0.15 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 3 Months Ended |
Mar. 31, 2021 | |
Fair Value Measurements [Abstract] | |
Assets and Liabilities Measured at Fair Value on Recurring Basis | The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at March 31, 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: March 31, Quoted Prices In Active Markets Significant Other Observable Inputs Significant Other Unobservable Inputs 2021 (Level 1) (Level 2) (Level 3) Assets: U.S. Money Market held in Trust Account $ 287,500,000 $ 287,500,000 $ - $ - Liabilities: Public Warrants Liability $ 9,415,625 - - $ 9,415,625 Private Placement Warrants Liability 6,768,334 - - 6,768,334 $ 16,183,959 $ - $ - $ 16,183,959 |
Fair Value Measurement Inputs | The key inputs into the Monte Carlo simulation as of February 23, 2021 and March 31, 2021 were as follows: Inputs (Initial Measurement) February 23, 2021 March 31, 2021 Risk-free interest rate 0.80 % 1.10 % Expected term remaining (years) 6.0 5.89 Expected term until Merger (years) 1.0 0.89 Estimated probability of successful Merger 50.0 % 50.0 % Expected volatility Pre-Merger 10.0 % 10.0 % Expected volatility Post-Merger 50.0 % 50.0 % Implied Stock price $ 10.86 $ 9.80 Exercise price $ 11.50 $ 11.50 |
Organization and Business Ope_2
Organization and Business Operations (Details) - USD ($) | Feb. 23, 2021 | Mar. 31, 2021 |
Description of Organization and Business Operations [Abstract] | ||
Gross proceeds from initial public offering | $ 281,750,000 | |
Gross proceeds from private placement | $ 7,750,000 | |
Transaction costs | $ 16,253,012 | |
Underwriting discount | 5,750,000 | |
Deferred underwriting discount | 10,062,500 | |
Other offering costs | 440,512 | |
Allocated expense associated with warrant liability | $ 621,678 | |
Cash deposited in Trust Account per Unit (in dollars per share) | $ 10 | |
Percentage of Public Shares that would not be redeemed if Business Combination is not completed within Initial Combination Period | 100.00% | |
Period to complete Business Combination from closing of Initial Public Offering | 24 months | |
Redemption price (in dollars per share) | $ 10 | |
Period to redeem Public Shares if Business Combination is not completed within Initial Combination Period | 10 days | |
Maximum [Member] | ||
Description of Organization and Business Operations [Abstract] | ||
Cash deposited in Trust Account per Unit (in dollars per share) | $ 10 | |
Interest from Trust Account that can be held to pay dissolution expenses | $ 100,000 | |
Private Placement Warrants [Member] | ||
Description of Organization and Business Operations [Abstract] | ||
Share price (in dollars per share) | $ 1.50 | |
Gross proceeds from private placement | $ 7,750,000 | |
Warrants issued (in shares) | 5,166,667 | 5,166,667 |
Initial Public Offering [Member] | ||
Description of Organization and Business Operations [Abstract] | ||
Units issued (in shares) | 28,750,000 | |
Share price (in dollars per share) | $ 10 | |
Gross proceeds from initial public offering | $ 287,500,000 | |
Transaction costs | 16,253,012 | |
Allocated expense associated with warrant liability | $ 621,678 | |
Initial Public Offering [Member] | Private Placement Warrants [Member] | ||
Description of Organization and Business Operations [Abstract] | ||
Number of securities called by each unit (in shares) | 0.25 | |
Warrants exercise price (In dollars per share) | $ 11.50 | |
Initial Public Offering [Member] | Class A Common Stock [Member] | ||
Description of Organization and Business Operations [Abstract] | ||
Number of securities called by each unit (in shares) | 1 | |
Number of securities called by each warrant (in shares) | 1 | |
Over-Allotment Option [Member] | ||
Description of Organization and Business Operations [Abstract] | ||
Units issued (in shares) | 3,750,000 | |
Share price (in dollars per share) | $ 10 | |
Gross proceeds from initial public offering | $ 5,750,000 |
Organization and Business Ope_3
Organization and Business Operations, Liquidity and Capital Resources (Details) - USD ($) | Feb. 23, 2021 | Dec. 31, 2020 | Mar. 31, 2021 |
Liquidity and Capital Resources [Abstract] | |||
Cash | $ 25,000 | $ 985,917 | |
Working capital | 1,500,000 | ||
Outstanding working capital loan | 0 | $ 0 | |
Sponsor [Member] | |||
Liquidity and Capital Resources [Abstract] | |||
Contribution from sale of founder shares | $ 25,000 | $ 25,000 | |
Sponsor [Member] | Maximum [Member] | |||
Liquidity and Capital Resources [Abstract] | |||
Unsecured promissory note | $ 300,000 |
Restatement of Previously Iss_3
Restatement of Previously Issued Financial Statements (Details) - USD ($) | Feb. 23, 2021 | Mar. 31, 2021 | Dec. 31, 2020 |
Impact of the Restatement [Abstract] | |||
Allocated expense associated with warrant liability | $ 621,678 | ||
Liability associated with Private Warrants in excess of Private Placement proceeds resulted in non-operating expense | 155,000 | $ 2,562,916 | |
Balance Sheet [Abstract] | |||
Total assets | 290,100,262 | 289,072,580 | $ 74,366 |
Liabilities and Stockholders' Equity [Abstract] | |||
Total current liabilities | 937,354 | 67,509 | 57,500 |
Warrant liability | 18,901,875 | 16,183,959 | 0 |
Total liabilities | 33,147,810 | 26,313,968 | 57,500 |
Class A common shares, $0.0001 par value; shares subject to possible redemption | 257,758,610 | 0 | |
Stockholders' Equity: | |||
Additional paid-in capital | 5,787,200 | 3,107,208 | 23,768 |
Accumulated deficit | (788,750) | 1,861,821 | (8,134) |
Total stockholders' equity | 5,000,006 | 5,000,002 | 16,866 |
Total Liabilities and stockholders' equity | 290,100,262 | $ 289,072,580 | $ 74,366 |
Common stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 | |
Class A Common Stock [Member] | |||
Liabilities and Stockholders' Equity [Abstract] | |||
Class A common shares, $0.0001 par value; shares subject to possible redemption | 255,108,035 | ||
Stockholders' Equity: | |||
Class A common stock - $0.0001 par value | $ 324 | $ 29,741 | $ 0 |
Common stock, par value (in dollars per share) | $ 0.0001 | $ 0.01 | $ 0.01 |
As Previously Reported [Member] | |||
Balance Sheet [Abstract] | |||
Total assets | $ 290,100,262 | ||
Liabilities and Stockholders' Equity [Abstract] | |||
Total current liabilities | 937,354 | ||
Warrant liability | 0 | ||
Total liabilities | 11,090,346 | ||
Stockholders' Equity: | |||
Additional paid-in capital | 5,010,711 | ||
Accumulated deficit | (12,072) | ||
Total stockholders' equity | 5,000,006 | ||
Total Liabilities and stockholders' equity | 290,100,262 | ||
As Previously Reported [Member] | Class A Common Stock [Member] | |||
Liabilities and Stockholders' Equity [Abstract] | |||
Class A common shares, $0.0001 par value; shares subject to possible redemption | 274,009,910 | ||
Stockholders' Equity: | |||
Class A common stock - $0.0001 par value | 135 | ||
Restatement Adjustment [Member] | |||
Balance Sheet [Abstract] | |||
Total assets | 0 | ||
Liabilities and Stockholders' Equity [Abstract] | |||
Total current liabilities | 0 | ||
Warrant liability | 18,901,875 | ||
Total liabilities | 18,901,875 | ||
Stockholders' Equity: | |||
Additional paid-in capital | 776,489 | ||
Accumulated deficit | (776,678) | ||
Total stockholders' equity | 0 | ||
Total Liabilities and stockholders' equity | 0 | ||
Restatement Adjustment [Member] | Class A Common Stock [Member] | |||
Liabilities and Stockholders' Equity [Abstract] | |||
Class A common shares, $0.0001 par value; shares subject to possible redemption | (18,901,875) | ||
Stockholders' Equity: | |||
Class A common stock - $0.0001 par value | $ 189 |
Significant Accounting Polici_4
Significant Accounting Policies, Cash and Cash Equivalents (Details) - USD ($) | Mar. 31, 2021 | Dec. 31, 2020 |
Cash and Cash Equivalents [Abstract] | ||
Cash equivalents | $ 0 | $ 0 |
Significant Accounting Polici_5
Significant Accounting Policies, Offering Costs Associated with the Initial Public Offering (Details) | Feb. 23, 2021USD ($) |
Offering Costs Associated with the Initial Public Offering [Abstract] | |
Transaction costs | $ 16,253,012 |
Allocated expense associated with warrant liability | 621,678 |
Initial Public Offering [Member] | |
Offering Costs Associated with the Initial Public Offering [Abstract] | |
Transaction costs | 16,253,012 |
Allocated expense associated with warrant liability | $ 621,678 |
Significant Accounting Polici_6
Significant Accounting Policies, Income Taxes (Details) - USD ($) | Mar. 31, 2021 | Dec. 31, 2020 |
Income Taxes [Abstract] | ||
Unrecognized tax benefits | $ 0 | $ 0 |
Accrued interest and penalties | $ 0 | $ 0 |
Significant Accounting Polici_7
Significant Accounting Policies, Net Loss Per Common Share and Reconciliation of Net Income per Common Share (Details) | 3 Months Ended |
Mar. 31, 2021USD ($)$ / sharesshares | |
Numerator [Abstract] | |
Interest earned on cash and marketable securities held in Trust Account | $ 0 |
Net income | 1,869,955 |
Class A Common Stock Subject to Possible Redemption [Member] | |
Numerator [Abstract] | |
Interest earned on cash and marketable securities held in Trust Account | 0 |
Net income attributable to shares subject to redemption | $ 0 |
Denominator [Abstract] | |
Basic weighted average shares outstanding (in shares) | shares | 25,517,968 |
Diluted weighted average shares outstanding (in shares) | shares | 25,517,968 |
Basic net income per share (in dollars per share) | $ / shares | $ 0 |
Diluted net income per share (in dollars per share) | $ / shares | $ 0 |
Non-redeemable Common Stock [Member] | |
Numerator [Abstract] | |
Net income | $ 1,869,955 |
Less: Income attributable to common stock subject to possible redemption | 0 |
Adjusted net income | $ 1,869,955 |
Denominator [Abstract] | |
Basic weighted average shares outstanding (in shares) | shares | 12,703,724 |
Diluted weighted average shares outstanding (in shares) | shares | 12,703,724 |
Basic net income per share (in dollars per share) | $ / shares | $ 0.15 |
Diluted net income per share (in dollars per share) | $ / shares | $ 0.15 |
Initial Public Offering and Private Placement [Member] | |
Net Loss per Common Share [Abstract] | |
Warrants sold in Initial Public Offering and private placement (in shares) | shares | 12,354,167 |
Initial Public Offering (Detail
Initial Public Offering (Details) - $ / shares | Feb. 23, 2021 | Mar. 31, 2021 |
Class A Common Stock [Member] | ||
Initial Public Offering [Abstract] | ||
Number of consecutive trading days | 20 days | |
Threshold trading days | 30 days | |
Class A Common Stock [Member] | Public Shares [Member] | ||
Initial Public Offering [Abstract] | ||
Number of shares included in Unit (in shares) | 1 | |
Number of securities called by each warrant (in shares) | 0.25 | |
Class A Common Stock [Member] | Public Warrants [Member] | ||
Initial Public Offering [Abstract] | ||
Number of warrants included in Unit (in shares) | 1 | |
Warrants exercise price (In dollars per share) | $ 11.50 | |
Period to exercise warrants after closing of Initial Public Offering | 12 months | |
Period to exercise warrants after Business Combination | 30 days | |
Expiration period of warrants | 5 years | |
Redemption of Warrants When Price Equals or Exceeds $18.00 [Member] | Class A Common Stock [Member] | Public Warrants [Member] | ||
Initial Public Offering [Abstract] | ||
Warrant redemption price (in dollars per share) | $ 0.01 | |
Redemption period | 30 days | |
Threshold trading days | 20 days | |
Number of trading days prior to notice of exercise being received | 3 days | |
Redemption of Warrants When Price Equals or Exceeds $18.00 [Member] | Class A Common Stock [Member] | Public Warrants [Member] | Minimum [Member] | ||
Initial Public Offering [Abstract] | ||
Share price (in dollars per share) | $ 18 | |
Redemption of Warrants When Price Equals or Exceeds $10.00 [Member] | Class A Common Stock [Member] | Public Warrants [Member] | ||
Initial Public Offering [Abstract] | ||
Share price (in dollars per share) | $ 10 | |
Number of securities called by each warrant (in shares) | 0.361 | |
Warrant redemption price (in dollars per share) | $ 0.10 | |
Redemption period | 30 days | |
Trading day period to calculate volume weighted average trading price following notice of redemption | 10 days | |
Initial Public Offering [Member] | ||
Initial Public Offering [Abstract] | ||
Units issued (in shares) | 28,750,000 | |
Share price (in dollars per share) | $ 10 | |
Initial Public Offering [Member] | Public Shares [Member] | ||
Initial Public Offering [Abstract] | ||
Units issued (in shares) | 28,750,000 | |
Share price (in dollars per share) | $ 10 | |
Initial Public Offering [Member] | Class A Common Stock [Member] | ||
Initial Public Offering [Abstract] | ||
Number of securities called by each warrant (in shares) | 1 | |
Initial Public Offering [Member] | Class A Common Stock [Member] | Public Shares [Member] | ||
Initial Public Offering [Abstract] | ||
Number of warrants included in Unit (in shares) | 1 | |
Over-Allotment Option [Member] | ||
Initial Public Offering [Abstract] | ||
Units issued (in shares) | 3,750,000 | |
Share price (in dollars per share) | $ 10 | |
Over-Allotment Option [Member] | Public Shares [Member] | ||
Initial Public Offering [Abstract] | ||
Units issued (in shares) | 3,750,000 | |
Share price (in dollars per share) | $ 10 | |
Additional Issue of Common Stock or Equity-Linked Securities [Member] | Public Warrants [Member] | ||
Initial Public Offering [Abstract] | ||
Number of consecutive trading days | 20 days | |
Percentage multiplier | 115.00% | |
Warrant redemption price (in dollars per share) | $ 18 | |
Additional Issue of Common Stock or Equity-Linked Securities [Member] | Public Warrants [Member] | Minimum [Member] | ||
Initial Public Offering [Abstract] | ||
Aggregate gross proceeds from issuance as a percentage of total equity proceeds | 60.00% | |
Additional Issue of Common Stock or Equity-Linked Securities [Member] | Public Warrants [Member] | Maximum [Member] | ||
Initial Public Offering [Abstract] | ||
Share price (in dollars per share) | $ 9.20 | |
Additional Issue of Common Stock or Equity-Linked Securities [Member] | Redemption of Warrants When Price Equals or Exceeds $18.00 [Member] | Public Warrants [Member] | ||
Initial Public Offering [Abstract] | ||
Percentage multiplier | 180.00% |
Private Placement (Details)
Private Placement (Details) - Private Placement Warrants [Member] - USD ($) | Feb. 23, 2021 | Mar. 31, 2021 |
Private Placement [Abstract] | ||
Warrants issued (in shares) | 5,166,667 | |
Share price (in dollars per share) | $ 1.50 | |
Gross proceeds from issuance of warrants | $ 7,750,000 | |
Holding period for transfer, assignment or sale of warrants | 30 days |
Related Party Transactions, Fou
Related Party Transactions, Founder Shares (Details) - USD ($) | Feb. 23, 2021 | Jan. 31, 2021 | Dec. 31, 2020 | Mar. 31, 2021 |
Founder Shares [Abstract] | ||||
Common stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 | ||
Class A Common Stock [Member] | ||||
Founder Shares [Abstract] | ||||
Common stock, par value (in dollars per share) | $ 0.0001 | 0.01 | $ 0.01 | |
Number of consecutive trading days | 20 days | |||
Threshold trading days | 30 days | |||
Class A Common Stock [Member] | Minimum [Member] | ||||
Founder Shares [Abstract] | ||||
Share price (in dollars per share) | $ 12 | |||
Period after initial Business Combination | 150 days | |||
Class B Common Stock [Member] | ||||
Founder Shares [Abstract] | ||||
Common stock, par value (in dollars per share) | 0.0001 | $ 0.0001 | ||
Class L Common Stock [Member] | ||||
Founder Shares [Abstract] | ||||
Common stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 | ||
Number of consecutive trading days | 20 days | |||
Threshold trading days | 30 days | |||
Sponsor [Member] | ||||
Founder Shares [Abstract] | ||||
Proceeds from issuance of common stock | $ 25,000 | $ 25,000 | ||
Sponsor [Member] | Class A Common Stock [Member] | ||||
Founder Shares [Abstract] | ||||
Holding period for transfer, assignment or sale of Founder Shares | 1 year | |||
Number of consecutive trading days | 20 days | |||
Threshold trading days | 30 days | |||
Sponsor [Member] | Class A Common Stock [Member] | Minimum [Member] | ||||
Founder Shares [Abstract] | ||||
Share price (in dollars per share) | $ 12 | |||
Period after initial Business Combination | 150 days | |||
Sponsor [Member] | Class B Common Stock [Member] | ||||
Founder Shares [Abstract] | ||||
Shares issued to sponsor (in shares) | 3,194,444 | 4,107,143 | ||
Common stock no longer subject to forfeiture (in shares) | 0 | |||
Sponsor [Member] | Class B Common Stock [Member] | Maximum [Member] | ||||
Founder Shares [Abstract] | ||||
Shares subject to forfeiture (in shares) | 416,667 | |||
Sponsor [Member] | Class L Common Stock [Member] | ||||
Founder Shares [Abstract] | ||||
Shares issued to sponsor (in shares) | 9,126,984 | 8,214,286 | ||
Common stock, par value (in dollars per share) | $ 0.002 | |||
Common stock no longer subject to forfeiture (in shares) | 0 | |||
Sponsor [Member] | Class L Common Stock [Member] | Maximum [Member] | ||||
Founder Shares [Abstract] | ||||
Shares subject to forfeiture (in shares) | 1,190,476 |
Related Party Transactions, Pro
Related Party Transactions, Promissory Note (Details) - Promissory Note [Member] - USD ($) | Dec. 22, 2020 | Feb. 25, 2021 |
Related Party Loans [Abstract] | ||
Borrowings outstanding | $ 115,492 | |
Sponsor [Member] | ||
Related Party Loans [Abstract] | ||
Related party transaction amount | $ 300,000 |
Related Party Transactions, Rel
Related Party Transactions, Related Party Loans (Details) - Working Capital Loans [Member] | 3 Months Ended |
Mar. 31, 2021USD ($)$ / shares | |
Related Party Transactions [Abstract] | |
Borrowings outstanding | $ 0 |
Sponsor, Affiliate of Sponsor, or Certain Company Officers and Directors [Member] | |
Related Party Transactions [Abstract] | |
Share price (in dollars per share) | $ / shares | $ 1.50 |
Sponsor, Affiliate of Sponsor, or Certain Company Officers and Directors [Member] | Maximum [Member] | |
Related Party Transactions [Abstract] | |
Related party transaction amount | $ 2,000,000 |
Commitments and Contingencies (
Commitments and Contingencies (Details) | Feb. 23, 2021USD ($)shares | Mar. 31, 2021USD ($)Demand |
Registration and Stockholder Rights [Abstract] | ||
Number of demands eligible security holder can make | Demand | 3 | |
Underwriting Agreement [Abstract] | ||
Term of option for underwriters to purchase additional units to cover over-allotments | 45 days | |
Additional units that can be purchased to cover over-allotments (in shares) | shares | 3,750,000 | |
Gross proceeds from initial public offering | $ 281,750,000 | |
Deferred underwriter fee discount | 3.50% | |
Deferred underwriting commissions | $ 10,062,500 | |
Over-Allotment Option [Member] | ||
Underwriting Agreement [Abstract] | ||
Underwriter fee discount | 2.00% | |
Gross proceeds from initial public offering | $ 5,750,000 |
Stockholders' Equity (Details)
Stockholders' Equity (Details) | 3 Months Ended | ||
Mar. 31, 2021TrancheVote$ / sharesshares | Feb. 23, 2021$ / shares | Dec. 31, 2020$ / sharesshares | |
Stockholders' Equity [Abstract] | |||
Preferred stock, shares authorized (in shares) | 1,000,000 | 1,000,000 | |
Preferred stock, par value (in dollars per share) | $ / shares | $ 0.0001 | $ 0.0001 | |
Preferred stock, shares issued (in shares) | 0 | 0 | |
Preferred stock, shares outstanding (in shares) | 0 | 0 | |
Common stock, shares authorized (in shares) | 15,000,000 | 15,000,000 | |
Common stock, par value (in dollars per share) | $ / shares | $ 0.0001 | $ 0.0001 | |
Common stock, shares issued (in shares) | 9,126,984 | 9,126,984 | |
Common stock, shares outstanding (in shares) | 9,126,984 | 9,126,984 | |
Stock conversion basis of Class B to Class A common stock at time of initial Business Combination | 1 | ||
As-converted percentage for Class A common stock after conversion of Class B shares | 10.00% | ||
Number of votes per share | Vote | 1 | ||
Class A Common Stock [Member] | |||
Stockholders' Equity [Abstract] | |||
Common stock, shares authorized (in shares) | 100,000,000 | 100,000,000 | |
Common stock, par value (in dollars per share) | $ / shares | $ 0.01 | $ 0.0001 | $ 0.01 |
Common stock, shares issued (in shares) | 2,974,139 | 0 | |
Common stock, shares outstanding (in shares) | 2,974,139 | 0 | |
Common stock, shares subject to possible redemption (in shares) | 25,775,861 | 0 | |
Number of consecutive trading days | 20 days | ||
Threshold trading days | 30 days | ||
Conversion of shares if First and Second Price Vesting targets will be met, $15.00 - $17.50 | 3,968,254 | ||
Conversion of shares if First and Second Price Vesting targets have been achieved, $17.50 | 1,984,127 | ||
Conversion of shares if First and Second Price Vesting targets have not been achieved, $17.50 | 5,952,381 | ||
Conversion of shares if First and Second Price Vesting targets have been achieved, $14.00 | 0 | ||
Class A Common Stock [Member] | Minimum [Member] | |||
Stockholders' Equity [Abstract] | |||
Share price (in dollars per share) | $ / shares | $ 12 | ||
Period after initial Business Combination | 150 days | ||
Class B Common Stock [Member] | |||
Stockholders' Equity [Abstract] | |||
Common stock, shares authorized (in shares) | 10,000,000 | 10,000,000 | |
Common stock, par value (in dollars per share) | $ / shares | $ 0.0001 | $ 0.0001 | |
Common stock, shares issued (in shares) | 3,194,444 | 3,194,444 | |
Common stock, shares outstanding (in shares) | 3,194,444 | 3,194,444 | |
Class L Common Stock [Member] | |||
Stockholders' Equity [Abstract] | |||
Common stock, shares authorized (in shares) | 15,000,000 | 15,000,000 | |
Common stock, par value (in dollars per share) | $ / shares | $ 0.0001 | $ 0.0001 | |
Common stock, shares issued (in shares) | 9,126,984 | 9,126,984 | |
Common stock, shares outstanding (in shares) | 9,126,984 | 9,126,984 | |
Number of tranches | Tranche | 4 | ||
Period after consummation of initial business combination, vesting price targets | 10 years | ||
Period after consummation of initial business combination, $15.00 - $17.50 | 15 months | ||
Percentage of shares converted | 25.00% | ||
Number of consecutive trading days | 20 days | ||
Threshold trading days | 30 days | ||
Number of votes per share | Vote | 1 | ||
Conversion of shares if First and Second Price Vesting targets will be met, $15.00 - $17.50 | 3,968,254 | ||
Threshold price if First and Second Price Vesting targets have been achieved, $17.50 | $ / shares | $ 17.50 | ||
Conversion of shares if First and Second Price Vesting targets have been achieved, $17.50 | 1,984,127 | ||
Threshold price if First and Second Price Vesting targets have not been achieved, $17.50 | $ / shares | $ 17.50 | ||
Conversion of shares if First and Second Price Vesting targets have not been achieved, $17.50 | 5,952,381 | ||
Threshold price if First and Second Price Vesting targets have been achieved, $14.00 | $ / shares | $ 14 | ||
Conversion of shares if First and Second Price Vesting targets have been achieved, $14.00 | 0 | ||
First Price Vesting [Member] | |||
Stockholders' Equity [Abstract] | |||
Share price (in dollars per share) | $ / shares | $ 12.50 | ||
Conversion of shares if First and Second Price Vesting targets will be met, $15.00 - $17.50 | 1,984,127 | ||
Second Price Vesting [Member] | |||
Stockholders' Equity [Abstract] | |||
Share price (in dollars per share) | $ / shares | $ 15 | ||
Conversion of shares if First and Second Price Vesting targets will be met, $15.00 - $17.50 | 1,984,127 | ||
Third Price Vesting [Member] | |||
Stockholders' Equity [Abstract] | |||
Share price (in dollars per share) | $ / shares | $ 17.50 | ||
Fourth Price Vesting [Member] | |||
Stockholders' Equity [Abstract] | |||
Share price (in dollars per share) | $ / shares | $ 20 | ||
Sponsor [Member] | Class A Common Stock [Member] | |||
Stockholders' Equity [Abstract] | |||
Holding period for transfer, assignment or sale of Founder Shares | 1 year | ||
Number of consecutive trading days | 20 days | ||
Threshold trading days | 30 days | ||
Sponsor [Member] | Class A Common Stock [Member] | Minimum [Member] | |||
Stockholders' Equity [Abstract] | |||
Share price (in dollars per share) | $ / shares | $ 12 | ||
Period after initial Business Combination | 150 days | ||
Sponsor [Member] | Class L Common Stock [Member] | |||
Stockholders' Equity [Abstract] | |||
Common stock, par value (in dollars per share) | $ / shares | $ 0.002 |
Fair Value Measurements, Assets
Fair Value Measurements, Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - Recurring [Member] | Mar. 31, 2021USD ($) |
Assets [Abstract] | |
U.S. Money Market held in Trust Account | $ 287,500,000 |
Liabilities [Abstract] | |
Warrant liability | 16,183,959 |
Public Warrants [Member] | |
Liabilities [Abstract] | |
Warrant liability | 9,415,625 |
Private Placement Warrants [Member] | |
Liabilities [Abstract] | |
Warrant liability | 6,768,334 |
Quoted Prices in Active Markets (Level 1) [Member] | |
Assets [Abstract] | |
U.S. Money Market held in Trust Account | 287,500,000 |
Liabilities [Abstract] | |
Warrant liability | 0 |
Quoted Prices in Active Markets (Level 1) [Member] | Public Warrants [Member] | |
Liabilities [Abstract] | |
Warrant liability | 0 |
Quoted Prices in Active Markets (Level 1) [Member] | Private Placement Warrants [Member] | |
Liabilities [Abstract] | |
Warrant liability | 0 |
Significant Other Observable Inputs (Level 2) [Member] | |
Assets [Abstract] | |
U.S. Money Market held in Trust Account | 0 |
Liabilities [Abstract] | |
Warrant liability | 0 |
Significant Other Observable Inputs (Level 2) [Member] | Public Warrants [Member] | |
Liabilities [Abstract] | |
Warrant liability | 0 |
Significant Other Observable Inputs (Level 2) [Member] | Private Placement Warrants [Member] | |
Liabilities [Abstract] | |
Warrant liability | 0 |
Significant Other Unobservable Inputs (Level 3) [Member] | |
Assets [Abstract] | |
U.S. Money Market held in Trust Account | 0 |
Liabilities [Abstract] | |
Warrant liability | 16,183,959 |
Significant Other Unobservable Inputs (Level 3) [Member] | Public Warrants [Member] | |
Liabilities [Abstract] | |
Warrant liability | 9,415,625 |
Significant Other Unobservable Inputs (Level 3) [Member] | Private Placement Warrants [Member] | |
Liabilities [Abstract] | |
Warrant liability | $ 6,768,334 |
Fair Value Measurements, Level
Fair Value Measurements, Level 3 Fair Value Measurement Inputs (Details) - Warrants [Member] | Mar. 31, 2021$ / shares | Feb. 23, 2021$ / shares |
Risk Free Rate [Member] | ||
Fair Value Measurements [Abstract] | ||
Measurement input | 0.0110 | 0.0080 |
Expected Term Remaining [Member] | ||
Fair Value Measurements [Abstract] | ||
Term | 5 years 10 months 20 days | 6 years |
Expected Term Until Merger [Member] | ||
Fair Value Measurements [Abstract] | ||
Term | 10 months 20 days | 1 year |
Estimated Probability of Successful Merger [Member] | ||
Fair Value Measurements [Abstract] | ||
Measurement input | 0.500 | 0.500 |
Expected Volatility Pre-Merger [Member] | ||
Fair Value Measurements [Abstract] | ||
Measurement input | 0.100 | 0.100 |
Expected Volatility Post-Merger [Member] | ||
Fair Value Measurements [Abstract] | ||
Measurement input | 0.500 | 0.500 |
Stock Price [Member] | ||
Fair Value Measurements [Abstract] | ||
Measurement input | 9.80 | 10.86 |
Exercise Price [Member] | ||
Fair Value Measurements [Abstract] | ||
Measurement input | 11.50 | 11.50 |